128 related articles for article (PubMed ID: 12044879)
1. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3.
Lee MH; Verma V; Maskos K; Becherer JD; Knäuper V; Dodds P; Amour A; Murphy G
FEBS Lett; 2002 Jun; 520(1-3):102-6. PubMed ID: 12044879
[TBL] [Abstract][Full Text] [Related]
2. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
[TBL] [Abstract][Full Text] [Related]
3. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase.
Lee MH; Knäuper V; Becherer JD; Murphy G
Biochem Biophys Res Commun; 2001 Jan; 280(3):945-50. PubMed ID: 11162616
[TBL] [Abstract][Full Text] [Related]
4. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
Lee MH; Dodds P; Verma V; Maskos K; Knäuper V; Murphy G
Biochem J; 2003 Apr; 371(Pt 2):369-76. PubMed ID: 12556225
[TBL] [Abstract][Full Text] [Related]
5. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2005 Apr; 280(16):15967-75. PubMed ID: 15713681
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
[TBL] [Abstract][Full Text] [Related]
7. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2004 Oct; 279(43):45121-9. PubMed ID: 15308656
[TBL] [Abstract][Full Text] [Related]
8. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
Gonzales PE; Solomon A; Miller AB; Leesnitzer MA; Sagi I; Milla ME
J Biol Chem; 2004 Jul; 279(30):31638-45. PubMed ID: 15100227
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex.
Wisniewska M; Goettig P; Maskos K; Belouski E; Winters D; Hecht R; Black R; Bode W
J Mol Biol; 2008 Sep; 381(5):1307-19. PubMed ID: 18638486
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
Amour A; Knight CG; Webster A; Slocombe PM; Stephens PE; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 2000 May; 473(3):275-9. PubMed ID: 10818225
[TBL] [Abstract][Full Text] [Related]
12. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
13. Mapping and characterization of the functional epitopes of tissue inhibitor of metalloproteinases (TIMP)-3 using TIMP-1 as the scaffold: a new frontier in TIMP engineering.
Lee MH; Maskos K; Knäuper V; Dodds P; Murphy G
Protein Sci; 2002 Oct; 11(10):2493-503. PubMed ID: 12237470
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
Troeberg L; Fushimi K; Scilabra SD; Nakamura H; Dive V; Thøgersen IB; Enghild JJ; Nagase H
Matrix Biol; 2009 Oct; 28(8):463-9. PubMed ID: 19643179
[TBL] [Abstract][Full Text] [Related]
16. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).
Milla ME; Leesnitzer MA; Moss ML; Clay WC; Carter HL; Miller AB; Su JL; Lambert MH; Willard DH; Sheeley DM; Kost TA; Burkhart W; Moyer M; Blackburn RK; Pahel GL; Mitchell JL; Hoffman CR; Becherer JD
J Biol Chem; 1999 Oct; 274(43):30563-70. PubMed ID: 10521439
[TBL] [Abstract][Full Text] [Related]
17. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
[TBL] [Abstract][Full Text] [Related]
18. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme.
Hansen HP; Dietrich S; Kisseleva T; Mokros T; Mentlein R; Lange HH; Murphy G; Lemke H
J Immunol; 2000 Dec; 165(12):6703-9. PubMed ID: 11120787
[TBL] [Abstract][Full Text] [Related]
19. Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.
Wu D; Gu Q; Zhao N; Xia F; Li Z
J Drug Target; 2015 Dec; 23(10):936-42. PubMed ID: 26061299
[TBL] [Abstract][Full Text] [Related]
20. Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
Lim NH; Kashiwagi M; Visse R; Jones J; Enghild JJ; Brew K; Nagase H
Biochem J; 2010 Oct; 431(1):113-22. PubMed ID: 20645923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
